<DOC>
	<DOCNO>NCT00998933</DOCNO>
	<brief_summary>To characterize transfer potential market testosterone gel new 1.62 % formulation .</brief_summary>
	<brief_title>Study Serum Testosterone Levels Non-dosed Females After Secondary Exposure</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Healthy male female volunteer , BMI 2035 kg/m2 ( male ) 2030 kg/m2 ( female ) . Males : history , current suspect prostate breast cancer . Female : pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Testosterone replacement therapy</keyword>
</DOC>